Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001673232-25-000011

PRESIDENT AND COO sold 22,500 shares at an average $452.07 ($10,171,683)

  • PRESIDENT AND COO acquired 14,625 shares (option exercise)
  • PRESIDENT AND COO acquired 7,875 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENKOWITZ MICHAEL · PRESIDENT AND COO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-10 Exercise or conversion : show line 1 in the form 10b5-1 −14,625 $135.42 $1,980,518 14,625 I
2025-11-10 Sale : show line 2 in the form 10b5-1 −14,625 $452.09 $6,611,870 0 I
2025-11-10 Exercise or conversion : show line 3 in the form 10b5-1 +7,875 $146.03 $1,149,986 7,875 I
2025-11-10 Sale : show line 4 in the form 10b5-1 −7,875 $452.04 $3,559,813 0 I
Open-market sales · 22,500 sh · avg $452.07 · $10,171,683

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-11-10 Exercise or conversion : show line 5 in the form 10b5-1 Stock Options −14,625 $135.42 2026-03-15 14,625 26,625 I
2025-11-10 Exercise or conversion : show line 6 in the form 10b5-1 Stock Options −7,875 $146.03 2026-03-15 7,875 2,625 I
Loading xslF345X05/primarydocument.xml…